Episode 57 – Molnupiravir for COVID-19 and Apixaban for Atrial Fibrillation in Hemodialysis

Welcome back Rounds Table Listeners!

We are back today with our Classic Rapid Fire Podcast!

This week, Drs. John and Mike Fralick discuss two recent papers – one, exploring the use of molnupiravir for the treatment of COVID-19 in adults at increased risk of adverse outcomes, and the second investigating the the use of apixaban in atrial fibrillation for patients on hemodialysis. Two papers, here we go!

  1. Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial (0:00 – 12:50).

  2. Apixaban for Patients With Atrial Fibrillation on Hemodialysis: A Multicenter Randomized Controlled Trial (12:50 – 25:00).

And for the Good Stuff:

Questions? Comments? Feedback? We’d love to hear from you! @roundstable

Leave a Comment

Your email address will not be published. Required fields are marked *

Republish this article

Republish this article on your website under the creative commons licence.

Learn more